ResMed Inc.
RMD
$219.72
-$0.50-0.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.93B | 4.81B | 4.69B | 4.58B | 4.50B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.93B | 4.81B | 4.69B | 4.58B | 4.50B |
| Cost of Revenue | 2.02B | 2.00B | 2.00B | 1.99B | 1.99B |
| Gross Profit | 2.91B | 2.80B | 2.69B | 2.59B | 2.52B |
| SG&A Expenses | 952.70M | 933.24M | 917.14M | 915.63M | 914.17M |
| Depreciation & Amortization | 76.02M | 77.17M | 79.49M | 80.95M | 82.45M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.37B | 3.33B | 3.30B | 3.30B | 3.29B |
| Operating Income | 1.56B | 1.48B | 1.38B | 1.29B | 1.22B |
| Income Before Tax | 1.53B | 1.38B | 1.26B | 1.18B | 1.10B |
| Income Tax Expenses | 286.27M | 263.22M | 243.85M | 225.49M | 207.44M |
| Earnings from Continuing Operations | 1.25K | 1.11K | 1.02K | 958.38 | 890.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.25B | 1.11B | 1.02B | 958.38M | 890.39M |
| EBIT | 1.56B | 1.48B | 1.38B | 1.29B | 1.22B |
| EBITDA | 1.71B | 1.63B | 1.53B | 1.44B | 1.37B |
| EPS Basic | 8.50 | 7.57 | 6.94 | 6.52 | 6.06 |
| Normalized Basic EPS | 6.55 | 6.14 | 5.67 | 5.22 | 4.89 |
| EPS Diluted | 8.47 | 7.55 | 6.93 | 6.51 | 6.05 |
| Normalized Diluted EPS | 6.52 | 6.12 | 5.65 | 5.21 | 4.87 |
| Average Basic Shares Outstanding | 587.55M | 587.87M | 588.08M | 588.18M | 588.14M |
| Average Diluted Shares Outstanding | 590.06M | 590.13M | 590.01M | 590.04M | 589.98M |
| Dividend Per Share | 2.02 | 1.97 | 1.92 | 1.88 | 1.84 |
| Payout Ratio | 23.76% | 26.02% | 27.65% | 28.85% | 30.39% |
